Medical Management of Rhinitis
Authors:
- 29 October 2025
- journal article
- review article
- Published by Elsevier in Immunology and Allergy Clinics of North America
- Vol. 46 (1) , 97-109
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Azelastine Nasal Spray for Prevention of SARS-CoV-2 InfectionsJAMA Internal Medicine, 2025
- Montelukast Use and the Risk of Neuropsychiatric Adverse Events in ChildrenJAMA Pediatrics, 2025
- Prednisolone versus antihistamine for allergic rhinitis: No significant difference found in randomized trialClinical and Translational Allergy, 2025
- Analysis of Neuropsychiatric Diagnoses After Montelukast InitiationJAMA Network Open, 2022
- Combined medical therapy in the treatment of allergic rhinitis: Systematic review and meta‐analysesInternational Forum of Allergy & Rhinology, 2022
- Worldwide prevalence of rhinitis in adults: A review of definitions and temporal evolutionClinical and Translational Allergy, 2022
- Hypothalamic‐pituitary‐adrenal axis suppression and intranasal corticosteroid use: A systematic review and meta‐analysisInternational Forum of Allergy & Rhinology, 2021
- Cumulative Use of Strong Anticholinergics and Incident DementiaJAMA Internal Medicine, 2015
- Superiority of an Intranasal Corticosteroid Compared With an Oral Antihistamine in the As-Needed Treatment of Seasonal Allergic RhinitisArchives of internal medicine (1960), 2001
- Toxicity of Over-the-Counter StimulantsJAMA, 1984